Assignee
GLENMARK PHARMACEUTICALS LTD
IN·29 granted patents·47 pending applications·116 citations·filing 2003–2025
Top patents by PatentIndex Score
76 records- 0192US9370483B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Jun 21, 2016·8 cites·21 claims
- 0290US9078923B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Jul 14, 2015·24 cites·21 claims
- 0384US7230002B2Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereofGLENMARK PHARMACEUTICALS LTD·Filed 2005·Granted Jun 12, 2007·6 cites·29 claims
- 0481US7649096B2Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamideGLENMARK PHARMACEUTICALS LTD·Filed 2006·Granted Jan 19, 2010·8 cites·9 claims
- 0581US7238725B2Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGLENMARK PHARMACEUTICALS LTD·Filed 2003·Granted Jul 3, 2007·21 cites·45 claims
- 0679US9695159B2Process for preparation of canagliflozinGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Jul 4, 2017·3 cites·9 claims
- 0777US12514996B2Metered dose inhalers of fluticasone or an ester thereofGLENMARK PHARMACEUTICALS LTD·Filed 2024·Granted Jan 6, 2026·0 cites·10 claims
- 0877US9670160B2Process for the preparation of tofacitinib and intermediates thereofGLENMARK PHARMACEUTICALS LTD·Filed 2013·Granted Jun 6, 2017·4 cites·20 claims
- 0976US2026091182A1Metered dose inhalers of fluticasone or an ester thereofGLENMARK PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 1071US10548907B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Feb 4, 2020·1 cites·32 claims
- 1170US2025064735A1Container system and pharmaceutical foam composition comprising betamethasoneGLENMARK PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1267US12514995B2Metered dose inhalers of fluticasone or an ester thereofGLENMARK PHARMACEUTICALS LTD·Filed 2022·Granted Jan 6, 2026·0 cites·7 claims
- 1367US7312329B2Process for the preparation of pyrimidine derivativesGLENMARK PHARMACEUTICALS LTD·Filed 2004·Granted Dec 25, 2007·11 cites·55 claims
- 1466US12502489B1Metered dose inhaler for ipratropium bromide solutionGLENMARK PHARMACEUTICALS LTD·Filed 2024·Granted Dec 23, 2025·0 cites·22 claims
- 1566US10106483B2Process for preparation of azelaic acidGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Oct 23, 2018·1 cites·12 claims
- 1665US2026077140A1Metered dose inhaler for ipratropium bromide solutionGLENMARK PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 1762US2011105448A1Stable Topical Formulation Comprising VoriconazoleGLENMARK PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 1861US7291745B2Process for the preparation of perindoprilGLENMARK PHARMACEUTICALS LTD·Filed 2006·Granted Nov 6, 2007·2 cites·15 claims
- 1959US2021196631A1Container system and pharmaceutical foam composition comprising betamethasoneGLENMARK PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2056USD795414SInhalerGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Aug 22, 2017·11 cites·1 claims
- 2156US2008118555A1Stable pharmaceutical composition containing desloratadineGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 2255US10646500B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted May 12, 2020·0 cites·15 claims
- 2355US10357622B2Dry powder inhalerGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Jul 23, 2019·1 cites·17 claims
- 2455USD797920SInhalerGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Sep 19, 2017·10 cites·1 claims
- 2552US7414143B2Process for the preparation of 4,4-dimethyl-6-ethynylthiochromanGLENMARK PHARMACEUTICALS LTD·Filed 2005·Granted Aug 19, 2008·0 cites·20 claims
- 2651US2019275269A1Dry Powder InhalerGLENMARK PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2751US2008014263A1Amorphous eprosartan mesylate and process for the preparation thereofGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 2850US2008071094A1Process for the preparation of perindoprilGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 2950US2008249120A1Pharmaceutical compositionsGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3048US9776985B2Process for preparation of alogliptinGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Oct 3, 2017·0 cites·11 claims
- 3148US2007275052A1Pharmaceutical compositions containing sterol inhibitorsGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3246US2007299123A1Amorphous frovatriptan succinate and process for the preparation thereofGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3345US6963002B2Process for the preparation of 4,4-dimethyl-6-ethynylthiochromanGLENMARK PHARMACEUTICALS LTD·Filed 2004·Granted Nov 8, 2005·0 cites·23 claims
- 3444US2007105927A1Amorphous rizatriptan benzoateGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 3544US2004185097A1Controlled release modifying complex and pharmaceutical compositions thereofGLENMARK PHARMACEUTICALS LTD·Filed 2004·Application pending·0 cites
- 3644US2009105350A1Process for the preparation of atovaquoneGLENMARK PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 3742US9499475B2Process for the preparation of arformoterol or salt thereofGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Nov 22, 2016·0 cites·11 claims
- 3842US2006111343A1Oxcarbazepine dosage formsGLENMARK PHARMACEUTICALS LTD·Filed 2005·Application pending·0 cites
- 3942US2007112055A1Crystalline forms of almotriptan and processes for their preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4042US2006281800A1Polymorphic form of olmesartan and process for its preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4142US2008014280A1Amorphous pregabalin and process for the preparation thereofGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 4242US2020345671A1Topical pharmaceutical composition of adapalene and minocyclineGLENMARK PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 4341US2007238881A1Process for the preparation of tazarotene intermediates and use thereof for the preparation of tazaroteneGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 4440US9840456B2Process for preparation of dimethyl fumarateGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Dec 12, 2017·0 cites·8 claims
- 4540US9663505B2Process for the preparation of rivaroxabanGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted May 30, 2017·0 cites·11 claims
- 4640US2007135472A1Novel crystalline forms of desloratadine and processes for their preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4740US2006084826A1Process for the preparation of naphthylmethylamine derivativesGLENMARK PHARMACEUTICALS LTD·Filed 2005·Application pending·0 cites
- 4840US2007105828A1Novel polymorph form M of mifepristone and process for its preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4940US2005249757A1Pharmaceutical cream formulationsGLENMARK PHARMACEUTICALS LTD·Filed 2005·Application pending·0 cites
- 5040US2006189670A1Process for the preparation of anastrozole and intermediates thereofGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →